Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sloan, JA; Loprinzi, CL; Laurine, JA; Novotny, PJ; Vargas-Chanes, D; Krook, JE; O'Connell, MJ; Kugler, JW; Tirona, MT; Kardinal, CG; Wiesenfeld, M; Tschetter, LK; Hatfield, AK; Schaefer, PL
   A simple stratification factor prognostic for survival in advanced cancer:The Good/Bad/Uncertain index
   JOURNAL OF CLINICAL ONCOLOGY
   
   J.A. Sloan et al., "A simple stratification factor prognostic for survival in advanced cancer:The Good/Bad/Uncertain index", J CL ONCOL, 19(15), 2001, pp. 3539-3546
2. Gostout, BS; Hartmann, LC; Suman, VJ; Fay, NE; Jefferies, JA; Morton, RF; Gaffey, TA; Farr, GH; Tschetter, LK; Abu-Ghazaleh, S; Gallenberg, MM; Hatfield, AK
   A randomized trial of interferon-alpha in cervical dysplasia
   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
   
   B.S. Gostout et al., "A randomized trial of interferon-alpha in cervical dysplasia", INT J GYN O, 74(2), 2001, pp. 207-210
3. Burch, PA; Ghosh, C; Schroeder, G; Allmer, C; Woodhouse, CL; Goldberg, RM; Addo, F; Bernath, AM; Tschetter, LK; Windschitl, HE; Cobau, CD
   Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer - A North Central Cancer Treatment Group Trial
   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
   
   P.A. Burch et al., "Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer - A North Central Cancer Treatment Group Trial", AM J CL ONC, 23(5), 2000, pp. 534-537
4. Burch, PA; Bernath, AM; Cascino, TL; Scheithauer, BW; Novotny, P; Nair, S; Buckner, JC; Pfeifle, DM; Kugler, JW; Tschetter, LK
   A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas
   INVESTIGATIONAL NEW DRUGS
   
   P.A. Burch et al., "A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas", INV NEW DR, 18(3), 2000, pp. 275-280
5. Tefferi, A; Levitt, R; Li, CY; Schroeder, G; Tschetter, LK; Michalak, JC; Krook, JE; Witzig, TE
   Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia
   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
   
   A. Tefferi et al., "Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia", AM J CL ONC, 22(5), 1999, pp. 509-516
6. Loprinzi, CL; Kugler, JW; Sloan, JA; Rooke, TW; Quella, SK; Novotny, P; Mowat, RB; Michalek, JC; Stella, PJ; Levitt, R; Tschetter, LK; Windschitl, H
   Lack of effect of coumarin in women with lymphedema after treatment for breast cancer
   NEW ENGLAND JOURNAL OF MEDICINE
   
   C.L. Loprinzi et al., "Lack of effect of coumarin in women with lymphedema after treatment for breast cancer", N ENG J MED, 340(5), 1999, pp. 346-350
7. Perry, A; Jenkins, RB; O'Fallon, JR; Schaefer, PL; Kimmel, DW; Mahoney, MR; Scheithauer, BW; Smith, SM; Hill, EM; Sebo, TJ; Levitt, R; Krook, J; Tschetter, LK; Morton, RF; Buckner, JC
   Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors - An analysis of DNA content (ploidy), cellular proliferation, and p53 expression
   CANCER
   
   A. Perry et al., "Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors - An analysis of DNA content (ploidy), cellular proliferation, and p53 expression", CANCER, 86(4), 1999, pp. 672-683
8. CREAGAN ET; HESTORRF RD; SUMAN VJ; MAILLIARD JA; NAIR S; KROOK JE; KUGLER JW; MARSCHKE RF; MICHALAK JC; TSCHETTER LK
   COMBINED LEVAMISOLE WITH RECOMBINANT INTERLEUKIN-2 (IL-2) IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY
   American journal of clinical oncology
   
   E.T. Creagan et al., "COMBINED LEVAMISOLE WITH RECOMBINANT INTERLEUKIN-2 (IL-2) IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY", American journal of clinical oncology, 21(2), 1998, pp. 139-141
9. CHONG SF; BRETSCHER ME; MAILLIARD JA; TSCHETTER LK; KIMMEL DW; HATFIELD AK; LOPRINZI CL
   PILOT-STUDY EVALUATING LOCAL-ANESTHETICS ADMINISTERED SYSTEMICALLY FOR TREATMENT OF PAIN IN PATIENTS WITH ADVANCED CANCER
   Journal of pain and symptom management
   
   S.F. Chong et al., "PILOT-STUDY EVALUATING LOCAL-ANESTHETICS ADMINISTERED SYSTEMICALLY FOR TREATMENT OF PAIN IN PATIENTS WITH ADVANCED CANCER", Journal of pain and symptom management, 13(2), 1997, pp. 112-117
10. ELLIOTT TE; DINAPOLI RP; OFALLON JR; KROOK JE; EARLE JD; MORTON RF; LEVITT R; TSCHETTER LK; SCHEITHAUER BW; PFEIFLE DM; TWITO DI; NELIMARK RA
    RANDOMIZED TRIAL OF RADIATION-THERAPY (RT) PLUS DIBROMODULCITOL (DBD)VERSUS RT PLUS BCNU IN HIGH-GRADE ASTROCYTOMA
    Journal of neuro-oncology
    
    T.E. Elliott et al., "RANDOMIZED TRIAL OF RADIATION-THERAPY (RT) PLUS DIBROMODULCITOL (DBD)VERSUS RT PLUS BCNU IN HIGH-GRADE ASTROCYTOMA", Journal of neuro-oncology, 33(3), 1997, pp. 239-250
11. ROWLAND KM; LOPRINZI CL; SHAW EG; MAKSYMIUK AW; KUROSS SA; JUNG SH; KUGLER JW; TSCHETTER LK; GHOSH C; SCHAEFER PL; OWEN D; WASHBURN JH; WEBB TA; MAILLIARD JA; JETT JR
    RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CISPLATIN AND ETOPOSIDE PLUS MEGESTROL-ACETATE PLACEBO IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY
    Journal of clinical oncology
    
    K.M. Rowland et al., "RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CISPLATIN AND ETOPOSIDE PLUS MEGESTROL-ACETATE PLACEBO IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY", Journal of clinical oncology, 14(1), 1996, pp. 135-141
12. LOPRINZI CL; ATHMANN LM; KARDINAL CG; OFALLON JR; SEE JA; BRUCE BK; DOSE AM; MISER AW; KERN PS; TSCHETTER LK; RAYSON S
    RANDOMIZED TRIAL OF DIETITIAN COUNSELING TO TRY TO PREVENT WEIGHT-GAIN ASSOCIATED WITH BREAST-CANCER ADJUVANT CHEMOTHERAPY
    Oncology
    
    C.L. Loprinzi et al., "RANDOMIZED TRIAL OF DIETITIAN COUNSELING TO TRY TO PREVENT WEIGHT-GAIN ASSOCIATED WITH BREAST-CANCER ADJUVANT CHEMOTHERAPY", Oncology, 53(3), 1996, pp. 228-232
13. HABERMANN TM; HARTMANN LC; TSCHETTER LK; WIEAND HS; EBBERT LP; MAILLIARD JA; LEVITT R; WITZIG TE; SUMAN V
    RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF G-CSF FOR FEBRILE-NEUTROPENIC PATIENTS
    Blood
    
    T.M. Habermann et al., "RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF G-CSF FOR FEBRILE-NEUTROPENIC PATIENTS", Blood, 88(10), 1996, pp. 1375-1375
14. LETENDRE L; LEVITT R; PIERRE RV; SCHROEDER G; KROOK JA; MAILLIARD JE; MORTON RF; TSCHETTER LK
    MYELODYSPLASTIC SYNDROME TREATMENT WITH DANAZOL AND CIS-RETINOIC ACID
    American journal of hematology
    
    L. Letendre et al., "MYELODYSPLASTIC SYNDROME TREATMENT WITH DANAZOL AND CIS-RETINOIC ACID", American journal of hematology, 48(4), 1995, pp. 233-236
15. LONG HJ; LANGDON RM; CHA SS; VEEDER MH; PFEIFLE DM; KROOK JE; EBBERT LP; TSCHETTER LK; ROSHON SG
    PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT ENDOMETRIAL CARCINOMA
    Gynecologic oncology
    
    H.J. Long et al., "PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT ENDOMETRIAL CARCINOMA", Gynecologic oncology, 58(2), 1995, pp. 240-243
16. LONG HJ; CROSS WG; WIEAND HS; WEBB MJ; MAILLIARD JA; KUGLER JW; TSCHETTER LK; KARDINAL CG; EBBERT LP; RAYSON S
    PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT CARCINOMA OF THE UTERINE CERVIX AND VAGINA
    Gynecologic oncology
    
    H.J. Long et al., "PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT CARCINOMA OF THE UTERINE CERVIX AND VAGINA", Gynecologic oncology, 57(2), 1995, pp. 235-239
17. BUCKNER JC; BROWN LD; KUGLER JW; CASCINO TL; KROOK JE; MAILLIARD JA; KARDINAL CG; TSCHETTER LK; OFALLON JR; SCHEITHAUER BW
    PHASE-II EVALUATION OF RECOMBINANT INTERFERON-ALPHA AND BCNU IN RECURRENT GLIOMA
    Journal of neurosurgery
    
    J.C. Buckner et al., "PHASE-II EVALUATION OF RECOMBINANT INTERFERON-ALPHA AND BCNU IN RECURRENT GLIOMA", Journal of neurosurgery, 82(3), 1995, pp. 430-435
18. CULLINAN SA; MOERTEL CG; WIEAND HS; OCONNELL MJ; POON MA; KROOK JE; MAILLIARD JA; TSCHETTER LK
    CONTROLLED EVALUATION OF 3 DRUG-COMBINATION REGIMENS VERSUS FLUOROURACIL ALONE FOR THE THERAPY OF ADVANCED GASTRIC-CANCER
    Journal of clinical oncology
    
    S.A. Cullinan et al., "CONTROLLED EVALUATION OF 3 DRUG-COMBINATION REGIMENS VERSUS FLUOROURACIL ALONE FOR THE THERAPY OF ADVANCED GASTRIC-CANCER", Journal of clinical oncology, 12(2), 1994, pp. 412-416
19. JETT JR; MAKSYMIUK AW; SU JQ; MAILLIARD JA; KROOK JE; TSCHETTER LK; KARDINAL CG; TWITO DI; LEVITT R; GERSTNER JB
    PHASE-III TRIAL OF RECOMBINANT INTERFERON-GAMMA IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER
    Journal of clinical oncology
    
    J.R. Jett et al., "PHASE-III TRIAL OF RECOMBINANT INTERFERON-GAMMA IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER", Journal of clinical oncology, 12(11), 1994, pp. 2321-2326
20. MAKSYMIUK AW; JETT JR; EARLE JD; SU JQ; DIEGERT FA; MAILLIARD JA; KARDINAL CG; KROOK JE; VEEDER MH; WIESENFELD M; TSCHETTER LK; LEVITT R
    SEQUENCING AND SCHEDULE EFFECTS OF CISPLATIN PLUS ETOPOSIDE IN SMALL-CELL LUNG-CANCER - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP RANDOMIZED CLINICAL-TRIAL
    Journal of clinical oncology
    
    A.W. Maksymiuk et al., "SEQUENCING AND SCHEDULE EFFECTS OF CISPLATIN PLUS ETOPOSIDE IN SMALL-CELL LUNG-CANCER - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP RANDOMIZED CLINICAL-TRIAL", Journal of clinical oncology, 12(1), 1994, pp. 70-76
21. EARLE JD; FOLEY JF; WIEAND HS; KVOLS LK; MCKENNA PJ; KROOK JE; TSCHETTER LK; SCHUTT AJ; TWITO DI
    EVALUATION OF EXTERNAL-BEAM RADIATION-THERAPY PLUS 5-FLUOROURACIL (5-FU) VERSUS EXTERNAL-BEAM RADIATION-THERAPY PLUS HYCANTHONE (HYC) IN CONFINED, UNRESECTABLE PANCREATIC-CANCER
    International journal of radiation oncology, biology, physics
    
    J.D. Earle et al., "EVALUATION OF EXTERNAL-BEAM RADIATION-THERAPY PLUS 5-FLUOROURACIL (5-FU) VERSUS EXTERNAL-BEAM RADIATION-THERAPY PLUS HYCANTHONE (HYC) IN CONFINED, UNRESECTABLE PANCREATIC-CANCER", International journal of radiation oncology, biology, physics, 28(1), 1994, pp. 207-211
22. LOPRINZI CL; BERNATH AM; SCHAID DJ; MALLIARD JA; ATHMANN LM; MICHALAK JC; TSCHETTER LK; HATFIELD AK; MORTON RF
    PHASE-III EVALUATION OF 4 DOSES OF MEGESTROL-ACETATE AS THERAPY FOR PATIENTS WITH CANCER ANOREXIA AND OR CACHEXIA/
    Oncology
    
    C.L. Loprinzi et al., "PHASE-III EVALUATION OF 4 DOSES OF MEGESTROL-ACETATE AS THERAPY FOR PATIENTS WITH CANCER ANOREXIA AND OR CACHEXIA/", Oncology, 51, 1994, pp. 2-7
23. LOPRINZI CL; GOLDBERG RM; OFALLON JR; QUELLA SK; MISER AW; MYNDERSE LA; BROWN LD; TSCHETTER LK; WILWERDING MB; DOSE AM; OESTERLING JE
    TRANSDERMAL CLONIDINE FOR AMELIORATING POSTORCHIECTOMY HOT FLASHES
    The Journal of urology
    
    C.L. Loprinzi et al., "TRANSDERMAL CLONIDINE FOR AMELIORATING POSTORCHIECTOMY HOT FLASHES", The Journal of urology, 151(3), 1994, pp. 634-636
24. DINAPOLI RP; BROWN LD; ARUSELL RM; EARLE JD; OFALLON JR; BUCKNER JC; SCHEITHAUER BW; KROOK JE; TSCHETTER LK; MAIER JA; PFEIFLE DM; GESME DH
    PHASE-III COMPARATIVE-EVALUATION OF PCNU AND CARMUSTINE COMBINED WITHRADIATION-THERAPY FOR HIGH-GRADE GLIOMA
    Journal of clinical oncology
    
    R.P. Dinapoli et al., "PHASE-III COMPARATIVE-EVALUATION OF PCNU AND CARMUSTINE COMBINED WITHRADIATION-THERAPY FOR HIGH-GRADE GLIOMA", Journal of clinical oncology, 11(7), 1993, pp. 1316-1321
25. GESME DH; JETT JR; SCHREFFLER DD; SU JQ; MAILLIARD JA; FOLEY JF; KROOK JE; MAKSYMIUK AW; HATFIELD AK; EBBERT LP; PFEIFLE DM; MORTON RF; TSCHETTER LK; SCHAEFER PL
    A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP
    Cancer
    
    D.H. Gesme et al., "A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP", Cancer, 71(9), 1993, pp. 2723-2726